INVOLVEMENT OF THE PERIAQUEDUCTAL GRAY AND AMYGDALA IN THE PANICOLYTIC EFFECT OF FLUOXETINE AND ALPRAZOLAM IN ANIMALS EXPOSED TO A PANICOGENIC STIMULUS

Vol 1, 2023 - 168837
Trabalho
Favoritar este trabalho
Como citar esse trabalho?
Resumo

Panic disorder (PD) is a chronic and disabling anxiety disorder characterized by spontaneous and recurrent panic attacks (PAs). Selective serotonin reuptake inhibitors (SSRI) and benzodiazepines are among the most frequently prescribed drugs for PD treatment. Despite their usefulness in PD, SSRI are associated with a delay for onset the therapeutic effects, which mechanism is unclear. A wealth of evidence suggest that PAs originate from a dysfunction in the brain’s fear network that integrates various structures such as periaqueductal gray and amygdala. Moreover, it is possible to highlight some important neurotransmitters involved in the fear-associated responses, and the nitrergic was investigated in this current study. In this context, it is important to elucidate the neurobiological basis of panic disorder and how antipanic drugs affect the critical brain regions.

Compartilhe suas ideias ou dúvidas com os autores!

Sabia que o maior estímulo no desenvolvimento científico e cultural é a curiosidade? Deixe seus questionamentos ou sugestões para o autor!

Faça login para interagir

Tem uma dúvida ou sugestão? Compartilhe seu feedback com os autores!

Eixo Temático
  • 18 - Neuropsicofarmacologia